Cassava Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SAVA and other ETFs, options, and stocks.

About SAVA

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx.

CEO

Richard Jon Barry

CEORichard Jon Barry

Employees

Employees30

Headquarters

Austin, Texas

HeadquartersAustin, Texas

Founded

1998

Founded1998

Employees

Employees30

SAVA Key Statistics

Market cap

105.31M

Market cap105.31M

Price-Earnings ratio

-1.45

Price-Earnings ratio-1.45

Dividend yield

—

Dividend yield—

Average volume

789.13K

Average volume789.13K

High today

$2.25

High today$2.25

Low today

$2.14

Low today$2.14

Open price

$2.23

Open price$2.23

Volume

556.93K

Volume556.93K

52 Week high

$33.98

52 Week high$33.98

52 Week low

$1.15

52 Week low$1.15

SAVA News

Seeking Alpha 2d

Cassava Sciences taps Joseph Hulihan as chief medical officer

Healthcare Cassava Sciences taps Joseph Hulihan as chief medical officer Aug. 07, 2025 7:48 AM ET Cassava Sciences, Inc. (SAVA) Stock By: Preeti Singh, SA News...

People also own

Based on the portfolios of people who own SAVA. This list is generated using Robinhood data, and it’s not a recommendation.